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Background: Stratification strategies based on identifying patient’s prognosis in order to guide patient care
constitute one of the most prominent and recent approach in low back pain research. The STarT Back Screening
Tool (SBST) although promising, has not been studied in patients with chronic low back pain (cLBP). Considering
how challenging it is to translate research into practice, the value of integrating a new tool should be thoroughly
assessed. The purpose was therefore to assess associations between the short- and long-terms clinical status and
two types of variables, physiologic measures and the SBST, in participants with cLBP. The ability of both types of
variables to discriminate between participants with and without higher levels of disability, pain, fear of movement
and patient’s global impression of change was also investigated.
Methods: Fifty-three volunteers with cLBP participated in an initial evaluation and follow-ups at 2-, 4-, 6- and 12-month.
Physiologic measures (maximal voluntary contraction, maximal endurance and muscle activity evaluated during prone
and lateral isometric tasks) and the SBST were assessed at baseline. Disability (Oswestry Disability Index, ODI), pain
intensity (101-point Numerical Rating Scale, NRS), fear of movement (Tampa Scale for Kinesiophobia, TSK) and patient’s
global impression of change (7-point scale, PGIC) were evaluated at baseline and at each follow-up. Aside the use of
correlation analyses to assess potential associations; ROC curves were performed to evaluate the discriminative ability of
physiologic measures and the SBST.
Results: The SBST allowed for the identification of participants presenting higher levels of disability (ODI ≥24 %), pain
(NRS ≥37 %) or fear of movement (TSK ≥41/68) over a 12-month period (AUC = 0.71 to 0.84, ps < 0.05). The SBST score
was also correlated with disability at each follow-up (τ = 0.22 to 0.33, ps < 0.05) and with pain intensity and fear of
movement at follow-ups. Among physiologic measures, only maximal voluntary contraction was correlated to disability,
pain intensity or fear of movement during the follow-up (|τ| = 0.26 to 0.32, ps < 0.05) and none was able to identify
participants presenting higher levels of outcomes (AUC ps > 0.05).
Conclusion: Physiologic measures obtained during prone and lateral tests have limited associations with the clinical
status over a 12-month period in patients with nonspecific chronic low back pain. On the other hand, the STarT Back
Screening Tool is useful for the identification of patients who will present higher levels of disability, pain intensity and fear
of movement over a year.
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Low back pain (LBP) constitutes a major public health
issue as more than 85 % of patients who suffer from it
are diagnosed with LBP of nonspecific origin [1]. The
2010 Global Burden of Disease Study reported LBP as
the leading musculoskeletal cause of years lived with
disability [2]. Moreover, a recent systematic review on
the natural history of LBP concluded that this condition
is relatively stable over time, and that becoming pain
free should be considered an exception rather than the
norm [3]. Considering the high prevalence of this con-
dition, the heterogeneous patient presentations and the
similar pattern of improvement characterizing a wide
range of primary care treatments, stratified care has
been identified as a research priority within the LBP
field [4–6]. Foster et al. [5] described stratified care as a
“strategy involving the identification of patient sub-
groups based on key characteristics such as their prog-
nostic profile, likely response to specific treatment and
suspected underlying causal mechanisms”. In addition,
Hingorani et al. [7] mentioned that stratified care aims
to optimize treatment, increase efficiency of healthcare
and reduce unnecessary harm.
One of the most prominent and recent approach deals
with targeting treatment to patient subgroups based on
patients prognosis [5]. Although some prognostic indicators
have been associated with long-term disability regardless of
the patient’s pain status (acute, subacute, or chronic LBP),
it is generally accepted that prognostic indicators can vary
according to nonspecific LBP duration [8]. Indeed, the
natural courses of acute, subacute and chronic LBP have
been reported to differ [9]. A literature review exploring
short- and long-term prognostic factors for pain intensity,
disability, return to work and global perceived effect in
patients with chronic nonspecific LBP has been recently
published [10]. The authors reported that only lower pain
intensity and lower physical job demands at baseline are
associated with one of the reported outcomes (i.e. earlier
return to work).
Considering the challenge of identifying prognostic fac-
tors, other research avenues emerged. Indeed, over the
past years, several questionnaires identifying patients risk
of persistent LBP and suggesting a stratified care have
been developed [11, 12]. One of these questionnaires, the
Subgroup for Targeted Treatment (STarT) Back Screening
Tool (SBST), which allows patients categorization into
three risk subgroups of persistent disabling LBP (low,
medium, or high risk subgroup), has increasingly been
studied since its validation in 2008 [13]. This tool has
mostly been validated for patients with LBP of any dur-
ation in primary care setting (e.g. [14, 15]); however, differ-
ent subgroups cut-offs might be observed in different
populations, such as in secondary care settings [16]. On
the other hand, trunk extension fitness (i.e. strength orendurance) and electromyography (EMG) power spectral
parameters of the low back obtained during these exer-
cises can predict first time LBP or symptoms recurrence
and discriminate between patients with and without LBP
[17–22]. Although heterogeneous results have been
reported regarding associations between trunk muscle
fitness and outcomes [23], trunk strength and endur-
ance tests are commonly used by health professionals
to initially evaluate patients with LBP, and exercises
are often prescribed as part of rehabilitation [24].
Various tests have been proposed to evaluate the trunk
extension fitness, but the Biering-Sørensen test (or the
modified Biering-Sørensen test [25]), is considered as
the gold standard [26]. The side-bridge test and its
modified versions, is also advocated in the evaluation
of patients with LBP since it results in lower compres-
sive forces than other trunk exercises [27].
Bearing in mind that it remains a challenge to imple-
ment new research evidences into clinical practice [28]
one can anticipate that clinicians will prefer stratified care
approaches based on commonly used physical tests rather
than a new and cost-effective tool such as the SBST [15].
Therefore, the aim of the present study was to assess the
associations between the short- (≤6 months) and long-
(12 months) terms clinical status and two types of vari-
ables, physiologic measures and the SBST, in patients with
chronic nonspecific LBP. As a second objective, the ability
of both types of variables to discriminate between partici-
pants with and without higher levels of disability, pain,
fear of movement and patient’s global impression of
change was investigated. It was hypothesized that both
physiologic measures and the SBST would be associated
to the short- and long-term clinical status, but that, based
on recent evidences, the SBST would present a higher
discriminative ability than physiologic measures.
Methods
Participants
Participants were recruited among the university’s commu-
nity and through an advertisement in the local newspaper.
Volunteers were first screened by clinicians at the outpa-
tients’ chiropractic clinic in order to assess for the various
inclusion and exclusion criteria. The inclusion criteria were
adults between 18 and 60 years old with nonspecific
chronic LBP, able to read and understand French. Nonspe-
cific LBP was defined as a pain located between the twelfth
rib and the inferior gluteal fold for which no specific source
of pain could be identified. “Chronic” was defined as a pain
present for 12 weeks or more, and included both constant
and recurrent patterns of pain. The exclusion criteria were
defined prior to the recruitment effort; they included LBP
of specific origin [1], spine surgery or trauma, scoliosis,
neurological disease, uncontrolled hypertension, pregnancy,
recent lumbar cortisone injection, being under medications
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lower body injury and/or severe, pain irradiating below the
knee [29], and disabling pain limiting the capacity to
undergo the evaluation. Once included in the study, partici-
pants were contacted by the researcher to schedule for
baseline assessment and to give their informed written con-
sent according to the university’s Human Research Ethics
Committee certification (No. CER-12-181-06.22).
Experimental protocol
The baseline assessment (T0) was conducted at the univer-
sity’s Neuromechanics and Motor Control Laboratory and
lasted approximately 2 h. Participants were first asked to
complete clinical questionnaires in order to assess lumbar
disability (Oswestry Disability Index, ODI), actual pain
intensity and mean pain intensity in the past 2 months
(101-point Numerical Rating Scale, NRS), fear of movement
(Tampa Scale for Kinesiophobia, TSK), and prognosis
(SBST [13]). All these questionnaires have been reported to
be reliable and responsive in the treatment of chronic LBP
and their French versions, which were used, have been vali-
dated [30–33]. The SBSTassesses the risk of poor prognosis
through nine questions relating to comorbidity, disability,
pain catastrophizing, fear of movement, bothersomeness,
anxiety and depression symptoms [13]. A scoring system
provides a risk group (low, medium, or high). Although a
psychological subscale is measured by items 5 to 9, the
present study only refers to the total score (range: 0 to 9).
Participants were then instructed to perform, in random-
ized sequences, isometric trunk muscle endurance tasks in
prone, right lateral and left lateral positions, each preceded
by a maximal isometric voluntary contraction (MVC) in
the same position. The experimental tasks were thoroughly
explained and demonstrated by the researcher before any
data were recorded. Lumbar muscle activity was collected
during prone endurance and MVC tasks using surface elec-
tromyography (EMG) matrices. Subsequently, participants
were contacted for a follow-up at 2 months (T1), 4 months
(T2), 6 months (T3), and 12 months (T4) by telephone,
email or mail, at the participant’s convenience.
MVC and endurance tasks
Prone and lateral tasks (Fig. 1) were performed according
to the protocols presented by Champagne et al. [25] and
Pagé and Descarreaux [34]. Lateral position tasks were
labelled according to the side up (i.e. when participants
were lying on the left side, the task was called right lateral
endurance or MVC task, as shown in Fig. 1b). Participants
were positioned on a 30° Roman chair, straight upper
body, the iliac crest aligned with the chair’s border and the
arms crossed on the chest. A fixed harness, installed over
their shoulders, was connected inline to a uni-axial force
transducer on the floor (NTEP-87-057A3 class III, Artech,
Riverside, CA, USA).A MVC task (prone, right and left lateral) was performed
just prior to the respective trunk endurance task by slowly
extending the trunk until feeling a tension on the harness
(straight body). At this point, the participants were asked to
perform a maximal trunk exertion contraction against the
harness for 5 s. A computer monitor was located in front of
the participant in order to provide him a visual feedback of
his/her performance. The first trial was performed without
feedback, but during the subsequent trials the participants
visualized a force threshold of 10 % superior to the previous
trial. MVC was considered completed when the partici-
pants could not reach the threshold, or after completing
three trials. During endurance tasks, the participants were
asked to maintain, as long as they could, 30 % ± 5 % of their
MVC carried out just before. A visual feedback was
provided using a computer monitor throughout the
task, in addition to verbal position correction provided
by the researcher. The task was considered “completed”
when the participants chose to stop or swayed too
much from the initial position (as evaluated by the
researcher) or target force. Two minutes of rest were
allowed between MVC and trunk endurance tasks. Verbal
encouragements were provided throughout endurance
and MVC tasks.
For data analyses, an average lateral position MVC
(variable defined as lateral MVC) and an average lateral
position endurance time (variable defined as lateral en-
durance) were calculated by averaging the MVCs and
endurance times obtained during right lateral position
task and left lateral position task.
EMG acquisition and analyses
EMG of right and left lumbar erector spinae was re-
corded during prone position tasks using two adhesive
matrices of 64 electrodes (model ELSCH064; LISiN-OT
Bioelettronica; Torino, Italy) as illustrated in Fig. 2. The
array grid consisted of 64 electrodes, 13 rows × 5 col-
umns (2 mm diameter, 12.5 mm inter-electrode dis-
tance). The electrode surfaces were separated from the
skin by a small cavity (approximately 1 mm thick) filled
with electrolyte gel (AC-CREAM250V; Spes Medica;
Battipaglia, Italy). The center of each grid was located at
L3 and two ground electrodes were placed on the right and
left olecranon processes. Skin impedance was reduced by
shaving body hair; gently abrading the skin with fine-grade
sandpaper (Red Dot Trace Prep, 3 M; St. Paul, MN, USA),
and wiping the skin with alcohol swabs. The bipolar EMG
signals were amplified (64-channel surface EMG amplifier,
SEA 64, LISiN-OT Bioelettronica; Torino, Italy; −3 dB
bandwidth 10–500 Hz) by a factor of 5000, sampled at
2048 Hz, and converted to digital form by a 12-bit
A/D converter. The data were collected using the
OT Bioelettronica custom software and processed by
Matlab (MathWorks; Natick, MA, USA).
Fig. 1 a. Prone position and b. Right lateral position. These positions were used to assess the endurance and the MVC of trunk muscles
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during isometric prone endurance task was digitally band-
pass filtered in the frequency bandwidth 20–450 Hz (2nd
order Butterworth filter). Notch filters were also applied to
reject 60 Hz power line interference and its harmonics.
Each electrode filtered signal was then divided in windows
of 0.5 s for which an individual root mean square (RMS)
value was computed and normalized with the correspond-
ing RMS obtained during prone MVC task. The center of
gravity of each two-dimensional representation of RMS
values was determined and the spatial migration of muscu-
lar activity throughout the endurance task was quantified.
Global mean migration of muscular activity (variable de-
fined as motor variability) was calculated by averaging both
left and right sides mean migration for each participant.
Individual median frequency (MF) value was also calcu-
lated for each window of 0.5 s. MF was defined as the
requency that divides the spectrum into two equal areas.
Median frequency slope (MFslope) was obtained from the
slope of a linear regression fit the MF values for each elec-
trode. The MFslopes were then divided by the initial MF
(iMF, t = 0) obtained from the interception of MFslope for
each electrode and averaged for each side (NMFslopeFig. 2 Matrices used in the recording of lumbar muscles activity
during prone position tasksin %S−1) [35]. Global NMFslope (variable defined as
NMFslope) was finally calculated by averaging both left
and right sides mean NMFslope for each participant.
Outcome assessments
At each follow-up assessment (T1, T2, T3 and T4), mean
pain intensity since the last follow-up, lumbar disability,
and fear of movement were re-evaluated in order to
quantify participant clinical status. Furthermore, a 7-
point patient’s global impression of change scale (PGIC)
at T3 and T4 was used to measure participant’s level of
perceived change in the past 6 months.
Dichotomous outcomes
All outcome variables (ODI, NRS, TSK and PGIC) were
re-coded into dichotomous outcomes at T3 and T4 based
on Wideman et al. [36] and Hill et al. [37]. Consistent with
these studies, presence of disability was defined as a
follow-up score of ≥24 % on the ODI, presence of pain as
a score of ≥37 % on the NRS, presence of fear of move-
ment as a score of ≥41 on the TSK, and presence of
subjective status change as a score of 1 or 2 (very much or
much improved) on the PGIC.
Approach to data analysis
Sample size was calculated using an estimated moderate
effect size (0.40 ≤ r ≤ 0.50 [38]) with a significance level of
0.05, a desired power of 0.80 and an estimated attrition of
10 %. Given the aforementioned requirements, the num-
ber of participants needed was between 51 (r = 0.40) and
32 (r = 0.50). The t-test for two samples was used to com-
pare baseline characteristics (age, body mass index, dis-
ability, fear of movement, pain intensity, SBST score,
endurance times and MVCs) between males and females,
and between participants and lost to follow-up.
To address our objectives, Kendall tau rank correlation
coefficient was computed to assess the relationship
between physiologic measures (endurance times, MVCs,
motor variability and NMFslope) and the SBST, and
clinical outcomes (NRS, ODI, TSK and PGIC) at T0, T1,
T2, T3 and T4: Kendall’s technique was used for all pairs
Fig. 3 Flow of participants through the study. Within parenthesis are the percentages of total participants at baseline (T0). Within brackets are the
means (± SD) of number of days for completion
Table 1 Participant’s baseline characteristics
Characteristic Mean ± SD
Number (female : male) 23 : 30
Age (years) 44.09 ± 13.26 (range : 21 to 60)
Employment
Unemployed : worker : retired 3 : 38 : 4
Housewife : student 1 :7
Weight (kg) 76.19 ± 15.27
Height (m) 1.70 ± 0.09
Body mass index (kg/m2) 26.14 ± 4.36
Duration of symptoms (months) 130.68 ± 112.03 (range : 4 to
360 months)
Reported physical activity by week (hours) 4.33 ± 3.27 (range : 0 to 14 h)
Initial disability (%) 18.38 ± 10.33
Initial fear of movement (/68) 36.42 ± 8.75
Initial pain intensity (%) 27.61 ± 22.94
Prone endurance (s) 57.46 ± 27.10
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normality requirements of Pearson’s correlation measure.
The importance of the correlation was evaluated as being
large (> 0.34), moderate (0.20–0.34) or small (< 0.19), using
equivalence formula between Pearson correlation coeffi-
cient and Kendall tau rank correlation [39]. The area under
the curve (AUC) statistic from receiver operating character-
istic (ROC) curves and 95 % confidence intervals (CI95)
were also used to describe the ability of the physiologic
measures and the SBST to identify participants presenting
disability, pain, fear of movement or an absence of subject-
ive status change at T3 and T4. Ability strength was defined
according to previous studies on the SBST : 0.7–0.8 indi-
cated acceptable ability, 0.8–0.9 indicated excellent ability
and 0.9 or over indicated outstanding ability [13]. When-
ever AUC was significant, predictive validity was assessed
by calculating sensitivity, specificity and positive and nega-
tive likelihood ratios (LRs) for different cut-offs values. It is
generally accepted that a positive LR higher than 10 signifi-
cantly increases the probability of the specific condition,
while a negative LR lower than 0.1 significantly decreases
the probability of the specific condition [40].
For all statistical analyses, p < 0.05 was considered to be
statistically significant. Statistical analysis was performed
using SPSS statistical package version 19.0.0.Lateral endurance (s) 31.73 ± 15.40
Prone MVCa (N) 147.90 ± 64.58
Lateral MVC (N) 112.67 ± 49.93
SBSTb risk group (low : moderate : high) 35 : 11 : 7
aMaximal isometric voluntary contraction
bSTarT Back Screening ToolResults
Study sample
The flow of participants through the study with reasons
for exclusion and lost to follow-up is presented in Fig. 3.
Overall, 53 volunteers - 30 males and 23 females with amean age of 44.09 years (range: 21–60) - with nonspe-
cific chronic LBP were included in the study. At least
87 % of the study sample completed each follow-up.
Baseline characteristics of the sample are summarized in
Table 1. No difference in baseline characteristics were
Table 2 Correlation coefficients between both the SBSTa and
physiologic measures, and outcome variables at baseline
Variable Disability Pain intensity Fear of movement
Prone endurance (s) −0.26* −0.04 −0.22*
Lateral endurance (s) −0.11 0.07 −0.17
Prone MVCb (N) −0.36* −0.02 −0.11
Lateral MVC (N) −0.11 −0.06 −0.02
Motor variability (cm) −0.27* −0.04 −0.21
NMFslopec (%S−1) 0.14 −0.15 0.23*
SBST score 0.43** 0.12 0.40**
Available paired data range from 53 down to 35, due to incomplete set of
EMG data. Note that Kendall tau rank correlation coefficients are reported and
that they are usually lower than Pearson r. Equivalence is determined by the
formula r ≈ sin(π × τ/2) [38]
*p < 0.05; **p < 0.001
aSTarT Back Screening Tool
bMaximal isometric voluntary contraction
cNormalized median frequency slope
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Since no differences were found between genders either,
all further statistical analyses were performed without
taking gender into account.
Correlations between SBST and physiologic measures,
and outcome variables
At baseline assessment, Kendall tau rank correlation coeffi-
cient analysis (see Table 2) showed that, few physiologic
measures were correlated to disability or fear of movement
(moderate or strong correlation) but any to pain intensity.
On the other hand, the SBST presented a strong correlation
with disability, and fear of movement. When correlation at
follow-ups were evaluated, only prone and lateral MVC
were significantly correlated to an outcome variables while
the SBST was correlated to disability at each follow-up, to
pain intensity at T4, and to fear of movement at T1. Inter-
estingly, the SBST was not correlated to PGIC at neither
T3 nor T4. Significant correlation coefficients are reported
in Table 3.
Discriminative ability of the SBST and physiologic measures
ROC analysis revealed that no physiologic singular-measure
had the ability to identify participants presenting higherTable 3 Correlation coefficients between both the SBSTa and physio
Variables Disability Pain in
T1 T2 T3 T4 T1
Prone MVCc (N) −0.26* −0.33** −0.16 −0.25 −0.04
Lateral MVC (N) −0.08 −0.29* −0.12 −0.30* −0.08
SBST score 0.31** 0.27* 0.27* 0.22* 0.17
Available paired data range from 49 down to 35 participants, due to technical prob
*p < 0.05; **p ≤ 0.01
aSTarT Back Screening Tool
b2-month (T1), 4-month (T2), 6-month (T3) and 12-month (T4) follow-ups
cMaximal isometric voluntary contractionlevels of disability (ODI ≥24 %), pain (NRS ≥37 %), fear of
movement (TSK ≥41/68) or absence of subjective status
change (PGIC ≥3/7) at T3 or T4. The SBST, however, had
an excellent ability to identify participants presenting higher
levels of disability at T3 and T4. It also presented an accept-
able ability in terms of pain at T3, and T4. Participants
presenting higher levels of fear of movement were only
significantly identified at T3. The SBST had no ability to
identify participants presenting an absence of subjective sta-
tus change at both T3 and T4. Significant ROC analyses are
presented in Fig. 4.
Since no significant AUC was found for physiologic
measures, all other parameters including sensitivity, spe-
cificity and positive and negative likelihood ratios (LRs)
were only calculated for different SBST cut-offs (see
Fig. 5 for sensitivity and specificity values). The cut-off
value of ≥ 4, which represents the proposed value to
discriminate between low and medium/high risk
groups of persistent disabling LBP [13], showed speci-
ficity values ranging between 72.1 and 78.1 % and
sensitivity values ranging between 42.9 and 75.0 % re-
garding disability and pain at T3 and T4, and fear of
movement at T3. Furthermore, positive and negative
LRs for this cut-off were ≤ 2.96 and ≥ 0.35 respectively,
depending on both the dichotomous outcomes and
the period evaluated. These LRs classify the SBST as a
“sometimes useful test” for identifying those presenting
disability, pain or fear of movement at 6- and 12-month
follow-ups.
Discussion
The present study was conducted to assess associations
between the short- (≤6 months) and long- (12 months)
terms clinical status and two types of variables, the
SBST and physiologic measures, in patients with
chronic LBP. The results showed that, while some
physiologic measures are only moderately associated
with clinical outcomes over a 12-month period, the
SBST questionnaire presents an acceptable or even
excellent ability to identify patients presenting higher
levels of disability, pain or fear of movement in both
the short- and long terms.logic measures, and outcome variables at follow-upsb
tensity Fear of movement
T2 T3 T4 T1 T2 T3 T4
−0.13 0.14 −0.10 0.04 0.13 0.32* 0.00
−0.25 −0.01 −0.03 0.05 0.07 0.22 0.09
0.10 0.18 0.34** 0.21* 0.15 0.18 0.16
lems and lost to follow-up
Fig. 4 ROC curves at 6- (full line) and 12- (dashed line) month for the SBST against outcome variables. Area under curve (AUC) are reported with
95 % CI in regard of a. Disability, b. Pain intensity and c. Fear of mbovement. * p < 0.05 and ** p≤ 0.01
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Physiologic measures, such as trunk endurance and MVC,
have been reported to be lower in patients with LBP com-
pared to healthy individuals [41, 42]. The present results
showed that only MVC obtained in prone or lateral
position is related to disability (50 % of the follow-ups) and
fear of movement (only at 6-month follow-up). Such results
raise concern related to the clinical relevance of physical
fitness tests with regard to the evolution of the clinical
status in patients with chronic LBP. Since patients withchronic LBP may limit their performance during endurance
and MVC tests due to fear of movement or catastrophizing
behaviors, some authors have proposed submaximal tests
performed in a nearly upright trunk posture [43] or sub-
maximal functional tests [44, 45]. These tests may better
reflect the true physical fitness of patients with chronic LBP
by the fact that patients do not have to perform maximal
efforts. However, the discriminative ability of these tests
remains to be investigated and compared to maximal
endurance and MVC tests.
Fig. 5 Sensitivity and specificity for STarT Back Screening Tool (SBST) cut-offs. Sensitivity and specificity in the identification of participants presenting
higher levels of disability (a), fear of movement (b), and pain (c) at 6- (T3) and 12-month (T4) follow-ups
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In contrast to physiologic measures, the SBST allowed for
the identification of participants presenting higher levels of
disability, pain, or fear of movement at 6 and 12 months
(except for fear of movement, which was only significant at
short-term). Previous studies reporting the SBST AUC
against disability presented results only for baseline analyses
[13, 37] or shorter follow-up periods (3-month [14] or 4-
month [36]) and involved patients reporting LBP of any
duration (acute, subacute or chronic). Because the natural
course of acute/subacute and chronic LBP differ, compari-
sons with previous studies are thus limited [9]. However,
regardless of LBP duration, the results of the present study
for short-term analyses may be compared to those
presented by Morso et al. [14]. The results of the present
study showed an excellent ability for the SBST to identify
participants presenting higher levels of disability at
6 months, while these authors reported only an acceptable
ability to identify patients with a score > 30 on the 101-
point Rolland Morris Disability Questionnaire (RMDQ;
which is equivalent to a score > 7 on the 25-point RMDQ)
at 3-month follow-up. Since an ODI score of 24 has been
reported to be equivalent to a RMDQ score of 7 [46], this
difference is likely explained by the fact that the Morso
et al. study mostly included patients with acute/subacute
LBP (63 %). This hypothesis is further supported by Morso
et al. [16] who reported a lower predictive ability in a
secondary care setting which included 80 % of patients with
chronic LBP.
The SBST cut-off between low and medium/high risk
groups of persistent disabling LBP has originally beendeveloped in patients presenting LBP of any duration (less
than 1 month to more than 3 years duration) [13]. These
authors reported sensitivity and specificity indices of 80.1
and 65.4 % respectively in identifying patients with a
RMDQ score of ≥ 7 at 6 months. For the same cut-off (i.e.
SBST cut-off ≥ 4), the present study showed a lower sensi-
tivity but a higher specificity at both short- (66.7 and
77.5 %) and long- (75.0 and 72.1 %) terms. Because the aim
of Hill et al. [13] study was to assess the external validity of
the SBST, the authors only presented the sensitivity and
specificity of the SBST cut-off ≥ 4 (for the total cohort and
for the 5 subgroups based on LBP duration). Nevertheless,
it would have been interesting to compare the results of the
present study to those of the chronic subgroups of patients
to confirm the presence of a different cut-off when only
patients with chronic LBP are evaluated.
Since the SBST was first developed and validated with
the intent to screen for back pain prognostic indicators
relevant to initial decision making in primary care for the
entire spectrum of patients with nonspecific LBP, the pres-
ence of “outcome dependant cut-offs” raises a concern with
regard to which outcome variable should be used to estab-
lish a stratified care strategy for chronic LBP. Along with
disability, pain, function and quality of life have also been
identified has important outcomes by patients with chronic
LBP [33] and should perhaps be considered in stratified
care approaches. For instance, the absence of significant
correlations between the SBST and the PGIC scale may
reflect the fact that other health related domains important
to patients with cLBP may not be captured by the SBST
questionnaire [30].
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The main strength of the present study is that it evaluated
the associations between the clinical status over a 12-
month period and two types of variables, physiologic mea-
sures and a brief questionnaire. Furthermore, this study
was able to attract a wide range of patients with chronic
LBP and maintain a low attrition rate, which increased its
ecological value. Most participants reported having being
treated for their LBP during the course of the study, which
may have affected the outcome measures. Nevertheless, this
is consistent with the definition of prognosis factors which
refers to generic predictors that are not necessarily unique
to a particular intervention [47]. Other limitations include
the inability of some participants to properly perform the
physical tests (endurance and MVC tasks) and the presence
of technical problems with EMG and MVC acquisition,
which generated a loss of data. Finally, future studies inves-
tigating subgroups of cLBP should consider using the SBST
as a categorical variable.
Conclusion
Although physiologic measures obtained during prone
and lateral tests (endurance and MVC) may be used to
initially evaluate physical fitness impairment in patients
with nonspecific chronic LBP, the results of the present
study showed that these tests have limited associations
with the clinical status over a 12-month period. On the
other hand, the SBST can identify patients presenting
higher levels of disability, pain or fear of movement at
short- (6-month) and long- (12-month) terms. However,
the SBST cut-off score that best identify participants varies
depending upon the period and the outcome variable eval-
uated. Considering the increasing use and usefulness of
the SBST, further studies should investigate how various
outcomes and subgroups cut-offs could help discriminate
between subpopulations of patients with low back pain.
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